Rockefeller Capital Management L.P. Immunome Inc. Transaction History
Rockefeller Capital Management L.P.
- $34.7 Billion
- Q2 2024
Shares
2 transactions
Others Institutions Holding IMNM
# of Institutions
122Shares Held
43.8MCall Options Held
67.2KPut Options Held
65.9K-
Redmile Group, LLC San Francisco, CA4.89MShares$63.5 Million3.86% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA3.88MShares$50.4 Million1.66% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.88MShares$50.3 Million0.03% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$48.8 Million0.0% of portfolio
-
Janus Henderson Group PLC London, X03.16MShares$41.1 Million0.02% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $157M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...